Medpace reports Q2 2022 revenue $351.2M (+26.2% YoY), diluted EPS $1.46 vs $1.06

Medpace Holdings, Inc.

2022-Q2 EPS reported $3.16 revenue$682,154,000

Revenue $351.2M, up 26.2% YoY; constant currency organic growth 27.7%.
GAAP net income $49.4M ($1.46 diluted EPS) vs $39.9M ($1.06) YoY.
Net new business awards $450.6M (book-to-bill 1.28x), up 16.3% YoY.
Backlog $2.2B, up 24.4% from $1.7B YoY.
EBITDA $68.1M (19.4% margin), up 42% YoY from $47.9M (17.2%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.